CA
MBRX icon

Clearstead Advisors’s Moleculin Biotech MBRX Stock Holding History

Clearstead Advisors’s Portfolio MBRX Stock Details MBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-40
Closed -$636 – 1402
2022
Q4 		$636 Buy
+40
New +$636 ﹤0.01% 1208